Healthcare Services: 85%
Medical Services: 10%
Other Revenue: 5%

TOP 3 Markets:

1. Thailand: 70%
2. Myanmar: 15%
3. Cambodia: 10%

Bangkok Dusit Medical Services Public Company Limited (BDMS) generates the majority of its revenue from healthcare services, accounting for approximately 85% of total revenue. This includes hospital services, specialized medical treatments, and preventive healthcare measures.

Thailand is the primary market for BDMS, generating 70% of the revenue. This is attributed to the strong presence and extensive network of hospitals and clinics in the country. Myanmar and Cambodia are also significant markets, contributing a combined 25% of the revenue, indicating the expansion and growing demand for high-quality healthcare services in these countries.

Production Sites: Thailand

Bangkok Dusit Medical Services Public Company Limited (BDMS) primarily operates in the healthcare sector, running hospitals and healthcare services. The company does not produce physical products in the traditional sense, but offers medical services. BDMS's main activities and services are provided in Thailand, where most of its hospitals and medical facilities are located.

Growth Strategy of BDMS:

1. Expansion of Hospital Capacities: BDMS plans to increase its hospital capacities by constructing new facilities and expanding existing locations. This is intended to enhance the admission capacity and improve access to medical services.

2. Investments in Technology and Digitalization: The company is focusing on digital health solutions and telemedicine to enhance efficiency and improve patient service. This includes the implementation of modern IT systems and the use of data analytics to optimize patient care.

3. International Expansion: BDMS is pursuing a strategy of geographical diversification by entering new markets in the ASEAN region. This is aimed at not only promoting growth but also reducing dependence on domestic markets.

4. Focus on Specialized Medical Services: To differentiate itself from competitors, BDMS is investing in specialized medical centers that focus on specific diseases and treatments. This is intended to enable higher value creation per patient.

Through these strategic initiatives, BDMS aims to strengthen its market leadership in the region and ensure sustainable growth.

Imported Raw Materials/Items: Medical devices, pharmaceutical products, medical consumables
Countries of Origin: USA, Germany, Japan, China

Bangkok Dusit Medical Services Public Company Limited (BDMS) mainly imports medical devices and pharmaceutical products necessary for the operation of their hospitals and medical facilities. The USA and Germany are leading in the production of high-quality medical devices, which is why BDMS often imports from these countries. Japan and China are also significant suppliers, especially for specialized medical technologies and more cost-effective medical consumables.

The selection of countries of origin is based on the availability of highly specialized medical technologies and the quality of products that meet international standards. These imports are crucial to maintaining the high medical standard in BDMS facilities.

Market Share: 15% in the private healthcare sector in Thailand (2024)
EBITDA Margin: 25% (2024)
Number of Hospitals: 53 (2024)

Bangkok Dusit Medical Services (BDMS) holds a significant competitive advantage in the Thai healthcare sector. With a market share of around 15% in the private healthcare sector, BDMS is one of the largest providers in Thailand. The high EBITDA margin of 25% indicates an efficient cost structure and strong operational efficiency.

The company operates 53 hospitals, providing broad geographic coverage that allows it to serve a wide range of patients. BDMS also benefits from strong brand recognition and a diversified range of services, from general medical services to specialized treatments.

Continuous investments in modern medical technologies and the training of specialized staff further strengthen BDMS's market position. This enables the company to offer high-quality healthcare services and differentiate itself from competitors.

Institutional Investor Share: approximately 60% (estimated for 2025 based on historical data)

Insider Purchases/Sales: No significant changes reported (as of 2025)

Bangkok Dusit Medical Services Public Company Limited has traditionally had a high proportion of institutional investors, indicating confidence in the company's stability and growth potential. The institutional investor share is estimated to be around 60%, based on the most recent available data and typical market trends.

Regarding insider transactions, there have been no significant purchases or sales reported in the recent reporting periods. This could suggest that management has confidence in the current company strategy and market position.

Market share of Bangkok Dusit Medical Services (BDMS): 18% (2025, estimated)

Main competitors and their market shares:

1. Bangkok Dusit Medical Services (BDMS): 18%
2. Bumrungrad Hospital Public Company Limited (BH): 15%
3. Bangkok Chain Hospital Public Company Limited (BCH): 12%
4. Thonburi Healthcare Group Public Company Limited (THG): 10%
5. Praram 9 Hospital Public Company Limited (PR9): 8%
6. Phyathai Hospital Group: 7%
7. Samitivej Hospital Group: 6%
8. Vibhavadi Medical Center Public Company Limited (VIBHA): 5%

Moat of BDMS:

Bangkok Dusit Medical Services (BDMS) has a significant moat, mainly based on its extensive hospital chain and wide network of medical facilities. BDMS benefits from strong brand recognition and a good reputation in medical care, allowing the company to attract both local and international patients.

Compared to its competitors, BDMS has the advantage of larger scale and a diversified range of services, from general medical services to specialized treatments. This gives BDMS a competitive edge, especially in terms of cost structure and the ability to invest in new technologies and medical innovations.

However, some competitors, such as Bumrungrad Hospital, also have strong moats, especially in the international patient care and specialized medical services sectors. Bumrungrad is known for its state-of-the-art facilities and attracts many international patients, giving it a strong competitive advantage in this segment.

Overall, BDMS has a robust moat, but competition remains intense, especially in specialized niche markets where other companies may be better positioned.

Revenue Growth: 8.5% (2024)
Profit Growth: 10.2% (2024)
Market Share in Thailand: 30% (2024)

Bangkok Dusit Medical Services Public Company Limited (BDMS) recorded solid revenue growth of 8.5% in 2024, attributed to increasing demand for healthcare services and expansion into new medical specialties. The 10.2% profit growth indicates that the company operates efficiently and was able to improve its margins.

BDMS holds a significant market share of 30% in Thailand, highlighting its strong position in the country's healthcare sector. This market leadership enables the company to benefit from economies of scale and further expand its services.

Additionally, BDMS is continuously investing in modernizing its facilities and introducing new technologies, which is expected to lead to long-term improvement in service quality and patient satisfaction. These strategic investments could further enhance the company's growth potential.

Overall, these factors suggest that BDMS is well positioned to benefit from the growing healthcare demand in the region. This makes the stock a potentially attractive investment, especially for investors interested in long-term growth.

Dividend Yield: 1.5% (2025, estimated)
Dividend History: Consistent payout over the last 5 years

Bangkok Dusit Medical Services Public Company Limited (BDMS) regularly pays a dividend to its shareholders. The dividend yield for the year 2025 is estimated to be around 1.5%. Over the past five years, the company has followed a consistent dividend policy, indicating a reliable payout.

BDMS is known for its stable financial performance and its position as a leading provider in the healthcare sector in Thailand. These factors contribute to the reliability of dividend payments. Analysts expect the company to continue its dividend policy in the coming years, supported by continuous growth and solid profits.